On September 13th, Canton Biologics Co., Ltd. announced that it had recently completed a Series C financing round exceeding 300 million yuan. This round of financing was led by SDIC Venture Capital, with participation from Guangdong Technology
/PRNewswire/ On September 13th, Canton Biologics Co., Ltd. announced that it had recently completed a Series C financing round exceeding 300 million yuan..
/PRNewswire/ The "Cell Line Development Services Global Market - Forecast To 2030" report has been added to ResearchAndMarkets.com s offering. The cell line.
/PRNewswire/ The "Cell Line Development Services Global Market - Forecast To 2030" report has been added to ResearchAndMarkets.com s offering. The cell line.
Glycotope to spin-out its Service Business to the newly formed FyoniBio GmbH Berlin, Germany, February 1, 2022 - Glycotope GmbH, a biotechnology company developing antibodies against proteins carrying